Cadila Healthcare has informed that the meeting of the Board of Directors of the Company will be held on Saturday, November 3, 2018 to consider apart from other agenda items to approve the unaudited financial results for the quarter / half year ended on September 30, 2018. Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI [Prohibition of Insider Trading] Regulations, 2015, the Trading Window will remain closed from October 23, 2018 to November 6, 2018 for all Directors and Designated Officers of the Company.
The above information is a part of company’s filings submitted to BSE.
